ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisFred Poordad, Barry Bernstein, Christophe Hézode et al.|New England Journal of Medicine|2014Cited by 877
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigmHomie Razavi, Achim Kautz, Imam Waked et al.|Journal of Viral Hepatitis|2014Cited by 484
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scoresCristiana Bianco, Luca Valenti, Oveis Jamialahmadi et al.|Journal of Hepatology|2020Cited by 361
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, Jinlin Hou, Jianqi Lian et al.|Journal of Hepatology|2020Cited by 346
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Thomas Berg, Miklós Sahin‐Tóth et al.|Nature Genetics|2006Cited by 250